Delivery Order SPE2DB20D2014-SPE2DB25FA41H
Award Date
11/22/24
Potential Completion Date
11/25/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $3,003.51, has a completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $3,816.98 and a period of performance through November 21, 2024. The award is a delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $2,002.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a critical pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,485.86 Firm Fixed Price Delivery Order contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, with an ultimate completion date of October 24, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
The federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $11,402.09. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,638.42 and a completion date of August 7, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, for the delivery of a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $28,708.54, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. It is a firm fixed-price delivery order contract with a completion date of February 10, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and has no major subcontractors...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,633.58 firm-fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, with a ceiling value of $3,511.44 and a completion date of August 2, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as...